Knowledge Highlight: Recombinant MYD1 Protein – A Core Tool for Innate Immunity Research

Published by ANT BIO PTE. LTD.

1. Core Concept

MYD1 recombinant protein is a bioactive protein produced via recombinant DNA technology, mimicking native MYD1 (a critical adaptor in the TLR/IL‑1R innate immune signaling pathway). It supports mechanistic studies, drug screening, autoantibody detection, and immunotherapy development.

[Image Position 1: Figure 1 – Domain architecture of MYD1 recombinant protein]

2. Research Frontier

Recent advances focus on high‑efficiency expression, native post‑translational modifications, structural resolution, and high‑throughput screening applications.

• Multi‑system expression (prokaryotic, eukaryotic, cell‑free) for tailored functional needs.
• Structural insights into MYD1–TLR4–IRAK4 signalosome assembly.
• Development of oxidation‑stable mutants and site‑specific labeling for live‑cell imaging.
• ELISA‑based autoantibody detection for autoimmune disease stratification.

[Image Position 2: Figure 2 – Workflow of recombinant MYD1 protein expression and purification]

3. Research Significance

MYD1 governs innate immune activation, inflammation, and disease progression. Recombinant MYD1 protein enables:

• Elucidation of TLR signaling mechanisms.
• High‑throughput screening of immunomodulators.
• Quantitative detection of anti‑MYD1 autoantibodies.
• Development of novel vaccine adjuvants and targeted therapies.

4. Molecular Mechanism & Research Methods

Key Domains

• N‑terminal Death Domain (DD): mediates protein–protein interactions.
• C‑terminal TIR Domain: drives signal transduction.

Expression Systems

• E. coli: High yield (15–20 mg/L), cost‑effective.
• Mammalian cells: Native phosphorylation (Y158, S76), high activity.
• Wheat germ cell‑free: Rapid synthesis, ideal for isotope labeling.

Quality Control & Applications

• Binding affinity (Kd ≈ 50 nM for TLR4‑TIR).
• NF‑κB reporter assay for functional validation.
• ELISA for autoantibody quantification.
• Cryo‑EM, SPR, and AlphaScreen for interaction and drug discovery.

5. Empowerment by ANT BIO PTE. LTD.

ANT BIO PTE. LTD. provides full‑stack reagents to support MYD1 research:

• UA (Recombinant Protein): High‑purity, bioactive MYD1 recombinant protein.
• Starter (Antibody): Specific anti‑MYD1 antibodies for detection and pulldown.
• Absin (Kits & Reagents): ELISA kits, reporter assays, purification resins, and buffers.

These products ensure reliable expression, validation, screening, and translation of MYD1 research.

6. Brand Mission

ANT BIO PTE. LTD. is committed to delivering high‑quality life science reagents and integrated solutions worldwide. We support breakthroughs in immunology, inflammation, and precision medicine by advancing recombinant proteins, antibodies, and detection tools.

7. Related Product List

表格

9. Brand Promotion Copy

ANT BIO PTE. LTD. – Empowering Scientific Breakthroughs

At ANTBIO, we are committed to advancing life science research through high-quality, reliable reagents and comprehensive solutions. Our specialized sub-brands (Absin, Starter, UA) cover a full spectrum of research needs, from general reagents and kits to antibodies and recombinant proteins. With a focus on innovation, quality, and customer-centricity, we strive to be your trusted partner in unlocking scientific mysteries and driving medical progress. Explore our product portfolio today and elevate your research to new heights.

Would you like me to convert this into a literature analysis version instead of the knowledge highlight version?